Physician profile
Cameron Lambert
NPI 1346583747
$98,934.61
in general payments reported to CMS, 2019-2025
35 companies · $1,040 in 2025
The $1,040 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,098 · 2020: $43K · 2021: $662 · 2022: $11K · 2023: $21K · 2024: $19K · 2025: $1,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $6,520 · Food and Beverage: $5,890 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,895 · Education: $2.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,224.26 |
| Travel and Lodging | $6,519.54 |
| Food and Beverage | $5,890.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,895.00 |
| Education | $2.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $31,909.04 | 2019-2020 | |
| Boston Scientific Corporation | $20,580.51 | 2019-2025 | Watchman Access System, Rhythmia Mapping System, General - Crm_crm |
| Biosense Webster, INC. | $20,063.14 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Na |
| Sanofi-Aventis U.S. LLC | $12,605.31 | 2021-2023 | |
| Abbott Laboratories | $8,312.35 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Biotronik INC. | $1,218.45 | 2021-2025 | Acticor 7 Vr-T Dx, Biomonitor, Selectra |
| Philips North America LLC | $1,168.25 | 2022-2025 | (9520) Igt Devices Und, Lm Undivided |
| Medtronic, INC. | $904.74 | 2021-2025 | Linq II, Micra, Reveal Linq |
| Masimo Corporation | $298.06 | 2023 | Patient Safetynet System, Set and Rainbow Set, Sedline |
| Irhythm Technologies, INC. | $263.47 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $248.77 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amgen INC. | $169.44 | 2022-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $147.16 | 2023 | Optimizer |
| Pfizer INC. | $121.66 | 2022-2025 | |
| Cvrx, INC. | $121.00 | 2022-2023 | Barostim Neo System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $113.44 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $111.75 | 2022-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $89.18 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.04 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $59.80 | 2021-2024 | Winrevair |
| Edwards Lifesciences Corporation | $47.56 | 2022-2024 | Sapien 3 Ultra Resilia |
| Lexicon Pharmaceuticals, INC. | $38.44 | 2024 | |
| Elutia, INC. | $35.93 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $31.28 | 2023 | Arcalyst |
| Abiomed | $28.20 | 2024 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $26.42 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.79 | 2023 | Lifevest |
| Cardiva Medical, INC. | $21.17 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kestra Medical Technology Services, INC. | $16.53 | 2024 | Assure Wcd |
| Cook Medical LLC | $14.91 | 2022 | |
| Esperion Therapeutics, INC. | $14.77 | 2022 | |
| Novo Nordisk INC | $14.53 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $13.58 | 2025 | Farxiga |
| Teleflex LLC | $12.94 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.